Ambu A/S (LON:0MJF)

Market Cap	3.21B
Revenue (ttm)	684.63M
Net Income (ttm)	41.25M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	77.83
Forward PE	36.90
Dividend	0.04 (0.04%)
Ex-Dividend Date	Dec 5, 2024

Volume	22,263
Average Volume	37,405
Open	104.30
Previous Close	105.67
Day's Range	104.10 - 105.40
52-Week Range	89.10 - 143.85
Beta	1.31
RSI	48.41
Earnings Date	Nov 5, 2025

About Ambu A/S

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,196
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0MJF

Financial Performance

In 2024, Ambu A/S's revenue was 5.39 billion, an increase of 12.90% compared to the previous year's 4.78 billion. Earnings were 235.00 million, an increase of 39.88%.

Financial numbers in DKK